Gerresheimer offers a complete package of primary packaging for biologics

The most important trend forecast by pharmaceutical experts is the continuing, worldwide increasing demand for biological drugs and biosimilars. With the recently founded, Gx Biological Solutions organization, Gerresheimer has installed a dedicated team to serve the highly specific requirements in the biological play field. The global biopharmaceuticals market is driven by various factors, such as the increase in the elderly population, surge in the prevalence of chronic diseases like cancer and diabetes, and growth in the adoption of biopharmaceuticals globally. Furthermore, a rise in strategic collaborations among biopharmaceuticals companies is also anticipated to supplement the growth of the biopharmaceutical industry. Biological drugs are specifically being used to treat, for example, rheumatism, diabetes, or cancer and are usually administered parenterally. They differ from conventional drugs in their molecular structure. Hence special demands on the primary packaging are to be taken care of. Gerresheimer has developed a complete package of services and products for these biological drugs and biosimilars. This includes a dedicated, innovative product portfolio consisting of specialty syringes and vials, safety devices, and more that…

Choose your subscription to read more